DA
BTX.WS

DSC Advisors’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History

DSC Advisors’s Portfolio BTX.WS Stock Details BTX.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-30,085
Closed -$5K – 80
2017
Q2 		$5K Buy
+30,085
New +$12.8K ﹤0.01% 60

Other funds holding BTX.WS

ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

DSC Advisors's BTX.WS Position: Q3 2017 in Review

DSC Advisors sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q3 2017, closing a stake of 30,085 shares — an estimated $5K sold.

DSC Advisors first reported a position in BTX.WS in Q2 2017 and held it in 1 quarter. The position peaked at $5K in Q2 2017. 33 funds tracked by Wall St. Rank hold BTX.WS as of Q3 2017.

  • DSC Advisors reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q3 2017 after selling out during the quarter.
  • DSC Advisors sold 30,085 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q3 2017, an estimated $5K.
  • DSC Advisors first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q2 2017 and held it in 1 quarter.
  • DSC Advisors's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $5K in Q2 2017.
  • 33 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q3 2017.

Based on DSC Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.